Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Long-term Outcomes After Transplantation of Donor Livers Preserved by Hypothermic Oxygenated Machine Perfusion (HOPE): a Retrospective Cohort Analysis of Real-world Data (IDEAL-D Stage 4)

NCT05520320 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05520320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05520320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Long-term Outcomes After Transplantation of Donor Livers Preserved by Hypothermic Oxygenated Machine Perfusion (HOPE): a Retrospective Cohort Analysis of Real-world Data (IDEAL-D Stage 4)
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Completed
Start date
August 24, 2022
Completion date
August 1, 2023
Enrollment
1,202 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypothermic machine perfusion, liver transplantation, organ preservation